Repligen Corporation (RGEN)
$173.88+6.13%Close
SELLBEAR · day 1
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $9.8B
- Beta
- 1.05
- P/E (TTM)
- 236.30
- Short % float
- 14.21%
- Days to cover
- 6.6
- SI change
- +12.9%
- 1W
- -4.30%
- 1M
- +5.59%
- vs SPY 1W
- -5.46%
- vs SPY 1M
- +2.59%
Industry peers
FMP comparable companies · ranked by market cap
- TMOBUYThermo Fisher Scientific Inc.$243.3BBULLQ 18$658.02+0.93%
- SOAGYSartorius AG ADR$84.1B$57.56
- ABUYAgilent Technologies, Inc.$48.2BBULLQ 16$170.54+1.41%
- SDMHFSartorius Stedim Biotech S.A.$23.5B$242.02
- TECHBUYBio-Techne Corporation$11.3BBULLQ 19$72.46+0.01%
- AVTRBUYAvantor, Inc.$10.6BBULLQ 4$15.67+1.82%
- BIOSELLBio-Rad Laboratories, Inc.$9.9BBULLQ 19$366.16+1.60%
- QGENBUYQiagen N.V.$9.4BRECOVERYQ 16$45.38+1.91%
- MRVIBUYMaravai LifeSciences Holdings, Inc.$2.1BCRISISQ -1$7.44+3.19%
- BLFSBUYBioLife Solutions, Inc.$1.9BBULLQ 11$38.61+0.00%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
ANALYST & RATINGS
LOADING…Loading analyst data…
Company news
FAQ
- What is LOPJLB’s current signal on RGEN?
- LOPJLB’s latest quantitative signal on Repligen Corporation (RGEN) is SELL in a BEAR regime. Signals are updated daily.
- What market regime is RGEN in?
- Repligen Corporation (RGEN) is currently classified in the BEAR HMM market regime on LOPJLB.
- What does Repligen Corporation (RGEN) do?
- Repligen Corporation specializes in the creation and distribution of advanced bioprocessing technologies and integrated systems. These solutions are vital for various stages of biological drug production, serving clients across North America, Europe, the Asia Pacific region, and other international markets. The company's diverse product portfolio includes crucial components for biomanufacturing…